LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 13 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $18,000 | -10.0% | 12,000 | 0.0% | 0.00% | – |
| Q1 2019 | $20,000 | -4.8% | 12,000 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -47.5% | 12,000 | +9.1% | 0.00% | – |
| Q3 2018 | $40,000 | -98.8% | 11,000 | -99.1% | 0.00% | -100.0% |
| Q2 2018 | $3,307,000 | -49.7% | 1,201,000 | -60.0% | 0.00% | -50.0% |
| Q1 2018 | $6,578,000 | -80.2% | 3,000,000 | -83.5% | 0.00% | -80.0% |
| Q4 2017 | $33,167,000 | +5.5% | 18,165,000 | +5.8% | 0.01% | 0.0% |
| Q3 2017 | $31,443,000 | -8.3% | 17,165,000 | -16.9% | 0.01% | -9.1% |
| Q2 2017 | $34,275,000 | +28.0% | 20,665,000 | +15.2% | 0.01% | +22.2% |
| Q1 2017 | $26,784,000 | +163.0% | 17,940,000 | +154.5% | 0.01% | +125.0% |
| Q4 2016 | $10,184,000 | -1.5% | 7,050,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $10,342,000 | +0.3% | 7,050,000 | +14.3% | 0.00% | 0.0% |
| Q2 2016 | $10,308,000 | -11.9% | 6,170,000 | -19.6% | 0.00% | -20.0% |
| Q1 2016 | $11,698,000 | +22.3% | 7,670,000 | +24.3% | 0.01% | +25.0% |
| Q4 2015 | $9,567,000 | +80.4% | 6,170,000 | +50.9% | 0.00% | +100.0% |
| Q3 2015 | $5,303,000 | – | 4,090,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|